Theodorus van der Kwast
Papers
3
Total Citations
102
H-Index
3
About
Theodorus van der Kwast is a leading authority in urologic pathology, with a research focus sharpened on prostate cancer diagnosis, staging, and treatment optimization. His major contributions center on refining risk stratification and therapeutic decision-making for clinically localized and node-positive prostate cancer. Notably, his 2021 systematic review on focal ablative therapy critically evaluated the evidence against standard management, highlighting significant limitations and providing crucial recommendations for clinical practice—a work that has garnered 52 citations. He has also advanced the understanding of lymph node dissection, systematically analyzing its benefits and harms during radical prostatectomy (28 citations) and pioneering the use of PSMA PET/CT for staging node-positive patients (22 citations). This latter work is particularly impactful, as it helps clarify whether molecular imaging findings can reliably guide treatment without the need for extended pelvic lymph node dissection. Through these rigorous systematic reviews and prognostic studies, van der Kwast has shaped evidence-based guidelines, directly influencing how clinicians balance treatment efficacy with patient morbidity. His work remains essential reading for urologists and pathologists seeking to navigate the complexities of prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3